首页 › 基金 › Redmile Group, LLC › INSM

Redmile Group, LLC 对 INSM 的持仓历史

INSMED INC · 医疗保健

Redmile Group, LLC 在 Q2 2026 的 13F 申报中披露持有 INSM(INSMED INC)51,234 股,市值约 US$5.5M,约占其申报组合的 0.37%,在其申报持仓中市值排名第 32 位。 Redmile Group, LLC 于 Q2 2026 首次申报该持仓。

最新持仓 (Q2 2026)51.23K 股
申报持仓市值$5.46M
组合权重0.37%
首次申报Q2 2026
最近变动新进
更新于2026-10-24

最后更新: 2026-10-24 · 来源: SEC EDGAR Form 13F-HR

Redmile Group, LLC 对 INSM 的持仓演变

Redmile Group, LLC 于 Q2 2026 首次披露 INSM 持仓:51,234 股(约 US$5.5M)。

逐季持仓明细

季度股数金额变化
Q2 2026 51.23K $5.46M 新进

关于 INSM 与 13F 数据

INSM(INSMED INC)属于医疗保健行业。我们追踪的基金中还有 40 只申报持有 INSM,申报仓位最大的包括:BAKER BROS. ADVISORS LP (US$937.8M), Darwin Global Management, Ltd. (US$673.6M), Orbis Allan Gray Ltd (US$647.9M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 INSM 的基金

查看 INSM 的全部基金持有人 →

常见问题

How long has Redmile Group, LLC held INSM?

Redmile Group, LLC has disclosed INSM holdings in 1 of the last 1 reported quarters, going back to Q2 2026.

What is Redmile Group, LLC's current position in INSM?

As of Q2 2026, Redmile Group, LLC holds 51.23K shares of INSM (INSMED INC), valued at $5.46M, representing 0.37% of its reported portfolio and ranking #32.

Has Redmile Group, LLC been buying or selling INSM?

In the latest 13F filing (Q2 2026), Redmile Group, LLC newly opened its position in INSM.

Which other funds hold INSM?

Other major institutional holders of INSM include BAKER BROS. ADVISORS LP, Darwin Global Management, Ltd., Orbis Allan Gray Ltd, among 40 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.